<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>SL4: Re: Risk, Reward, and Human Enhancement</title>
<meta name="Author" content="Robin Gane-McCalla (robinganemccalla@gmail.com)">
<meta name="Subject" content="Re: Risk, Reward, and Human Enhancement">
<meta name="Date" content="2008-01-04">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>Re: Risk, Reward, and Human Enhancement</h1>
<!-- received="Fri Jan  4 00:55:36 2008" -->
<!-- isoreceived="20080104075536" -->
<!-- sent="Thu, 3 Jan 2008 23:53:32 -0800" -->
<!-- isosent="20080104075332" -->
<!-- name="Robin Gane-McCalla" -->
<!-- email="robinganemccalla@gmail.com" -->
<!-- subject="Re: Risk, Reward, and Human Enhancement" -->
<!-- id="857718430801032353p2f20dea7gb8ee888ff769d68e@mail.gmail.com" -->
<!-- charset="ISO-8859-1" -->
<!-- inreplyto="7b249e3c0801032329t751f5b54r289ad358bc365770@mail.gmail.com" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Robin Gane-McCalla (<a href="mailto:robinganemccalla@gmail.com?Subject=Re:%20Risk,%20Reward,%20and%20Human%20Enhancement"><em>robinganemccalla@gmail.com</em></a>)<br>
<strong>Date:</strong> Fri Jan 04 2008 - 00:53:32 MST
</p>
<!-- next="start" -->
<ul>
<li><strong>Next message:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Previous message:</strong> <a href="17417.html">Anthony Tross: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>In reply to:</strong> <a href="17417.html">Anthony Tross: "Re: Risk, Reward, and Human Enhancement"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Reply:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Reply:</strong> <a href="17421.html">Stathis Papaioannou: "Re: Risk, Reward, and Human Enhancement"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#17418">[ date ]</a>
<a href="index.html#17418">[ thread ]</a>
<a href="subject.html#17418">[ subject ]</a>
<a href="author.html#17418">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
Does anybody think that psychedelics might be the drug that acts
<br>
randomly upon intelligence, either increasing it or decreasing it?
<br>
Some people go crazy and others have great insights.
<br>
<p>On Jan 3, 2008 11:29 PM, Anthony Tross &lt;<a href="mailto:tonytross@gmail.com?Subject=Re:%20Risk,%20Reward,%20and%20Human%20Enhancement">tonytross@gmail.com</a>&gt; wrote:
<br>
<em>&gt; I think that Shulgin and his wife are undoubtedly brave psychonauts and
</em><br>
<em>&gt; should be greatly thanked for their tireless efforts. As well, I don't think
</em><br>
<em>&gt; that there is any question that triptamines, ergotamines, and various other
</em><br>
<em>&gt; neuroactive substances are in some way responsible for our ability to be
</em><br>
<em>&gt; insightful. It is widely accepted that psychedelics can precipitate
</em><br>
<em>&gt; synesthesic states, and must have contributed intrinsically to our sense of
</em><br>
<em>&gt; beauty. I imagine that we would still be unicameral (biblically, please!)
</em><br>
<em>&gt; were it not for drugs, fire, and so language.
</em><br>
<em>&gt;
</em><br>
<em>&gt; Nootropics are an entirely different kettle of brain-bath goodies, primarily
</em><br>
<em>&gt; intended for optimal function in the present, and perhaps after the results
</em><br>
<em>&gt; of longitudinal studies are tallied, valuable in neuroprotection as we age.
</em><br>
<em>&gt; With computed intelligence we don't have to worry about ageing, as such, but
</em><br>
<em>&gt; must consider instilling psychedelic or, more accurately, standalone
</em><br>
<em>&gt; algorithmic creativity that runs as a complementary process.
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt; On Jan 2, 2008 11:59 PM, Stathis Papaioannou &lt;<a href="mailto:stathisp@gmail.com?Subject=Re:%20Risk,%20Reward,%20and%20Human%20Enhancement">stathisp@gmail.com</a>&gt; wrote:
</em><br>
<em>&gt; &gt; On 03/01/2008, Bryan Bishop &lt;<a href="mailto:kanzure@gmail.com?Subject=Re:%20Risk,%20Reward,%20and%20Human%20Enhancement">kanzure@gmail.com</a>&gt; wrote:
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt; &gt; The Shulgin phikal story seems to be an excellent example. From what I
</em><br>
<em>&gt; &gt; &gt; can tell, Shulgin became a biochemist and started experimenting with
</em><br>
<em>&gt; &gt; &gt; nootropics in the 1970s, meticulously recording experiences and results
</em><br>
<em>&gt; &gt; &gt; starting with the smallest of dosages of each of his synthesized
</em><br>
<em>&gt; &gt; &gt; compounds. Frankly, you have to be smart to not kill yourself.
</em><br>
<em>&gt; &gt; &gt; Nootropical experimentalism is *not* for everyone.
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt; Mostly hallucinogens and stimulants rather than what is commonly
</em><br>
<em>&gt; &gt; referred to as nootropics. It's an almost unique example of
</em><br>
<em>&gt; &gt; systematic, rigorous research and self-experimentation in
</em><br>
<em>&gt; &gt; psychopharmacology. Predictably, Shulgin was prosecuted by the US DEA
</em><br>
<em>&gt; &gt; for his efforts.
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt; &gt; --
</em><br>
<em>&gt; &gt; Stathis Papaioannou
</em><br>
<em>&gt; &gt;
</em><br>
<em>&gt;
</em><br>
<em>&gt;
</em><br>
<p><p><p><pre>
-- 
Robin Gane-McCalla
YIM: Robin_Ganemccalla
AIM: Robinganemccalla
</pre>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Previous message:</strong> <a href="17417.html">Anthony Tross: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>In reply to:</strong> <a href="17417.html">Anthony Tross: "Re: Risk, Reward, and Human Enhancement"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Reply:</strong> <a href="17419.html">Lucas Sheehan: "Re: Risk, Reward, and Human Enhancement"</a>
<li><strong>Reply:</strong> <a href="17421.html">Stathis Papaioannou: "Re: Risk, Reward, and Human Enhancement"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#17418">[ date ]</a>
<a href="index.html#17418">[ thread ]</a>
<a href="subject.html#17418">[ subject ]</a>
<a href="author.html#17418">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Wed Jul 17 2013 - 04:01:01 MDT
</em></small></p>
</body>
</html>
